Compare ALDX & LSBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ALDX | LSBK |
|---|---|---|
| Founded | 2004 | 1891 |
| Country | United States | United States |
| Employees | 7 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 103.1M | 123.3M |
| IPO Year | 2014 | 2025 |
| Metric | ALDX | LSBK |
|---|---|---|
| Price | $1.76 | $16.11 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $5.50 | N/A |
| AVG Volume (30 Days) | ★ 988.2K | 11.6K |
| Earning Date | 05-01-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 2.27% |
| EPS Growth | 40.43 | ★ 49.23 |
| EPS | N/A | ★ 0.26 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $62.31 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.07 | $11.50 |
| 52 Week High | $6.18 | $16.28 |
| Indicator | ALDX | LSBK |
|---|---|---|
| Relative Strength Index (RSI) | 52.08 | 63.59 |
| Support Level | $1.49 | $14.57 |
| Resistance Level | $1.88 | $16.28 |
| Average True Range (ATR) | 0.15 | 0.17 |
| MACD | 0.02 | 0.05 |
| Stochastic Oscillator | 54.02 | 94.74 |
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma, and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.
Lake Shore Bancorp Inc operates as a savings and loan holding company. The bank's business consists of attracting retail deposits from the general public in the areas surrounding its branch offices and investing those deposits, together with funds generated from operations, in commercial real estate loans, one-to-four family residential mortgage loans, home equity lines of credit, and, to a lesser extent, commercial business loans, consumer loans, and investment securities. Its revenues are principally derived from interest earned on loans and investment securities.